Biogen director granted 1,505 RSUs in equity award
Minor Lloyd reported acquisition or exercise transactions in this Form 4 filing.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Minor Lloyd reported acquisition or exercise transactions in this Form 4 filing.
Biogen Inc. director Lloyd Minor received an equity award of 1,505 restricted stock units. These units were granted at no cash cost and increase his direct holdings to 3,875 shares of common stock. The restricted stock units vest on the earlier of the next annual meeting or the June 9, 2026 grant anniversary.
Insider Trade Summary
Grant/Award: 1,505 shares
Grant/Award
1 txn
Insider
Minor Lloyd
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,505 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 3,875 shares (Direct)
Holdings Before and After:
Common Stock, 2,370 to 3,875 shares (Direct)
Footnotes (1)
- F1. The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.
Key Figures
Equity award size: 1,505 units
Holdings after award: 3,875 shares
Grant price per share: $0.0000
+2 more
5 metrics
Equity award size
1,505 units
Restricted stock units granted to director Lloyd Minor
Holdings after award
3,875 shares
Total Biogen common stock directly held after transaction
Grant price per share
$0.0000
No cash cost for restricted stock unit grant
Transaction code
A
Grant, award, or other acquisition of equity
Vesting date reference
June 9, 2026
Latest possible vesting date; earlier of next annual meeting or this date
Key Terms
restricted stock units, annual meeting, Form 4, Grant, award, or other acquisition
4 terms
restricted stock units financial
"The restricted stock units vest on the earlier of (i) the next annual meeting"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
annual meeting regulatory
"vest on the earlier of (i) the next annual meeting or (ii) the anniversary"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Biogen (BIIB) director Lloyd Minor report?
Lloyd Minor reported receiving an award of 1,505 restricted stock units. These are compensation-related equity units, not an open-market stock purchase, and they will convert into common shares when they vest under the specified schedule.
Was Lloyd Minor’s Biogen (BIIB) equity grant an open-market stock purchase?
No, the filing shows a Form 4 code "A" grant or award. The 1,505 units were provided as an equity compensation award at no stated purchase price, rather than shares bought by Minor in the open market.
When do Lloyd Minor’s Biogen (BIIB) restricted stock units vest?
The restricted stock units vest on the earlier of the next annual meeting or the June 9, 2026 grant anniversary. This means vesting is tied to either shareholder meeting timing or the one-year mark from the award date.
What does the Form 4 code "A" mean in the Biogen (BIIB) filing?
In this Form 4, transaction code "A" indicates a grant, award, or other acquisition. It confirms that the 1,505 units were issued as an equity award to Lloyd Minor rather than acquired through a purchase transaction in the open market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
